Showing results (61-70 of 214) with videos related to
Sort By:
Pageof 22
Clinical Chemistry and Laboratory Medicine|February 5, 2009
High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solutionDorte L Lildballe, Tore F Hardlei, Lindsay H Allen, et al.Molecular Biology of the Cell|December 20, 2018
Kinetic analysis of transcellular passage of the cobalamin-transcobalamin complex in Caco-2 monolayersChristian B Juul, Sergey N Fedosov, Ebba Nexo, et al.Brain Research|February 13, 2013
Vitamin B₁₂ dependent changes in mouse spinal cord expression of vitamin B₁₂ related proteins and the epidermal growth factor systemElena Mutti, Dorte L Lildballe, Lise Kristensen, et al.Clinical Laboratory|February 7, 2017
Testosterone Measured with an Automatic Immunoassay Compares Reasonably Well to Results Obtained by LC-MS/MSCindy S Knudsen, Carsten S Hoejskov, Holger J Moller, et al.Clinical Chemistry and Laboratory Medicine|July 29, 2011
Trefoil factor family peptides are increased in the saliva of children with mucositisFran Verey, Ebba Nexo, Rosemary Greenwood, et al.Clinical Chemistry|September 17, 2005
Nonradioactive vitamin B12 absorption test evaluated in controls and in patients with inherited malabsorption of vitamin B12Mustafa Vakur Bor, Mualla Cetin, Selin Aytaç, et al.Clinical Chemistry|December 31, 2005
The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birthRima Obeid, Anne L Morkbak, Winfried Munz, et al.Parkinson'S Disease|March 14, 2015
Salivary acetylcholinesterase activity is increased in Parkinson's disease: a potential marker of parasympathetic dysfunctionTatyana Fedorova, Cindy Soendersoe Knudsen, Kim Mouridsen, et al.Journal of the National Cancer Institute|November 20, 2013
Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort studyJohan Frederik Berg Arendt, Lars Pedersen, Ebba Nexo, et al.Melanoma Research|June 5, 2004
S100beta protein in peripheral blood may predict progressive disease during interleukin-2 based immunotherapy in patients with metastatic melanomaHenrik Schmidt, Boe S Sorensen, Ebba Nexo, et al.Pageof 22